Skip to content

Clinical trials

Phase 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 3 Country / region: Brazil Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20073
20081
20092
20111
20121
20161
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Bristol-Myers Squibb1
Gamida Cell ltd1
Hospital Israelita Albert Einstein1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive12
Leukemia4
Hematologic Neoplasms3
Bone Marrow Diseases2
Leukemia, Myeloid2
Leukemia, Myeloid, Acute2
Myelodysplastic Syndromes2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Bronchiolitis Obliterans Syndrome1
Graft vs Host Disease1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.